NCT05269771 2025-11-05
MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera
Novartis
No longer available
Clinical Trials
6 trialsNCT05219266 2024-06-28
Managed Access Programs for PKC412, Midostaurin
Novartis
No longer available
NCT03592576 2024-05-06
Expanded Access to Navitoclax
AbbVie
No longer available
NCT04518644 2023-04-28
Nilotinib, for Patients With CML-CP or CML-AP
Novartis
No longer available
NCT00302016 2011-08-26
Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
Novartis
No longer available
NCT00413270 2011-07-13
Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant
Novartis
No longer available